<DOC>
	<DOCNO>NCT02011737</DOCNO>
	<brief_summary>The purpose study evaluate Efficacy Safety oral intake Naftopidil 75mg daily improve clearance ureteral renal stone .</brief_summary>
	<brief_title>Naftopidil 75mg Improving Clearance Urinary Stones</brief_title>
	<detailed_description>Prospective , Single-center , Double blind , Randomized control trial Treatment - Oral Naftopidil 75 mg daily give patient schedule shockwave lithotripsy ( ESWL ) ureteral renal stone . Follow Assessments include X-ray ( KUB ) , visual analogue pain scale , do 2 , 4 , 6 week ESWL .</detailed_description>
	<mesh_term>Calculi</mesh_term>
	<mesh_term>Kidney Calculi</mesh_term>
	<mesh_term>Nephrolithiasis</mesh_term>
	<mesh_term>Ureteral Calculi</mesh_term>
	<mesh_term>Ureterolithiasis</mesh_term>
	<mesh_term>Naftopidil</mesh_term>
	<criteria>Radioopaque ( identifiable KUB ) ureter kidney calculus size criterion 5mm 15mm Symptomatic acute urinary tract infection runin period severe hydronephrosis 2 urinary stone Radiolucent ( nonvisible KUB ) stone recent intervention urinary stone within 6 month Patients ureteral stent 2.0 mg/dl serum creatinine level severe hepatic dysfunction orthostatic hypotension current usage alphaadrenergic blocker calcium channel blocker Pregnant nursing woman Age 15 year severe uncontrolled medical condition</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>December 2013</verification_date>
	<keyword>Medical Expulsive therapy</keyword>
</DOC>